Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nicox, Re-Vana partner for sustained-release formulations for IOP

Nicox S.A. (Euronext:COX) and Re-Vana Therapeutics Ltd. (Belfast, U.K.) partnered to develop

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE